Gevoeligheid van Belgische Mycoplasma hyopneumoniae-isolaten voor antimicrobiële middelen

D. Maes; J. Vicca; T. Stakenborg; P. Butaye; A. De Kruif; F. Haesebrouck

doi:10.21825/vdt.87582

Gevoeligheid van Belgische Mycoplasma hyopneumoniae-isolaten voor antimicrobiële middelen

Translated title of the contribution: In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates

D. Maes
, J. Vicca
, T. Stakenborg
, P. Butaye
, A. De Kruif
, F. Haesebrouck

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

1 Citation (Scopus)

Abstract

To control Mycoplasma hyopneumoniae infections, the use of antibiotics in feed or water is a common practice. Unfortunately, information concerning the susceptibility of M. hyopneumoniae to different antimicrobials is very scarce. The in vitro susceptibility of 21 M. hyopneumoniae field isolates was determined in this study using a broth microdilution technique. Acquired resistance to spectinomycin, oxytetracycline, doxycycline, gentamicin, florfenicol and tiamulin was not observed. One isolate showed acquired resistance to lincomycin, tilmicosin and tylosin, but was susceptible to all other antibiotics tested. For 5 isolates, the MIC-values of flumequine were 16 μg/ml, while the MIC⁵⁰-value was 2 μg/ml. The MIC-values of enrofloxacin for these 5 isolates were ≥ 0.5 μg/ml, the MIC⁵⁰ being 0.06 μg/ml. This is the first report showing acquired resistance against macrolides, lincosamides and fluoroquinolones in M. hyopneumoniae field isolates.

Translated title of the contribution	In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates
Original language	Dutch
Pages (from-to)	300-305
Journal	Vlaams Diergeneeskundig Tijdschrift
Volume	76
Issue number	4
Online published	20 Aug 2007
DOIs	https://doi.org/10.21825/vdt.87582
Publication status	Published - 2007
Externally published	Yes

Bibliographical note

Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].

Access Output

10.21825/vdt.87582

Other Access Options

Check CityUHK Library

Permanent Link

Right click to copy link

Cite this

@article{277625e551c044789ba6bd315603da88,

title = "Gevoeligheid van Belgische Mycoplasma hyopneumoniae-isolaten voor antimicrobi{\"e}le middelen",

abstract = "To control Mycoplasma hyopneumoniae infections, the use of antibiotics in feed or water is a common practice. Unfortunately, information concerning the susceptibility of M. hyopneumoniae to different antimicrobials is very scarce. The in vitro susceptibility of 21 M. hyopneumoniae field isolates was determined in this study using a broth microdilution technique. Acquired resistance to spectinomycin, oxytetracycline, doxycycline, gentamicin, florfenicol and tiamulin was not observed. One isolate showed acquired resistance to lincomycin, tilmicosin and tylosin, but was susceptible to all other antibiotics tested. For 5 isolates, the MIC-values of flumequine were 16 μg/ml, while the MIC50-value was 2 μg/ml. The MIC-values of enrofloxacin for these 5 isolates were ≥ 0.5 μg/ml, the MIC50 being 0.06 μg/ml. This is the first report showing acquired resistance against macrolides, lincosamides and fluoroquinolones in M. hyopneumoniae field isolates.",

author = "D. Maes and J. Vicca and T. Stakenborg and P. Butaye and \{De Kruif\}, A. and F. Haesebrouck",

note = "Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].",

year = "2007",

doi = "10.21825/vdt.87582",

language = "Dutch",

volume = "76",

pages = "300--305",

journal = "Vlaams Diergeneeskundig Tijdschrift",

issn = "0303-9021",

publisher = "Universiteit Gent",

number = "4",

}

TY - JOUR

T1 - Gevoeligheid van Belgische Mycoplasma hyopneumoniae-isolaten voor antimicrobiële middelen

AU - Maes, D.

AU - Vicca, J.

AU - Stakenborg, T.

AU - Butaye, P.

AU - De Kruif, A.

AU - Haesebrouck, F.

N1 - Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].

PY - 2007

Y1 - 2007

N2 - To control Mycoplasma hyopneumoniae infections, the use of antibiotics in feed or water is a common practice. Unfortunately, information concerning the susceptibility of M. hyopneumoniae to different antimicrobials is very scarce. The in vitro susceptibility of 21 M. hyopneumoniae field isolates was determined in this study using a broth microdilution technique. Acquired resistance to spectinomycin, oxytetracycline, doxycycline, gentamicin, florfenicol and tiamulin was not observed. One isolate showed acquired resistance to lincomycin, tilmicosin and tylosin, but was susceptible to all other antibiotics tested. For 5 isolates, the MIC-values of flumequine were 16 μg/ml, while the MIC50-value was 2 μg/ml. The MIC-values of enrofloxacin for these 5 isolates were ≥ 0.5 μg/ml, the MIC50 being 0.06 μg/ml. This is the first report showing acquired resistance against macrolides, lincosamides and fluoroquinolones in M. hyopneumoniae field isolates.

AB - To control Mycoplasma hyopneumoniae infections, the use of antibiotics in feed or water is a common practice. Unfortunately, information concerning the susceptibility of M. hyopneumoniae to different antimicrobials is very scarce. The in vitro susceptibility of 21 M. hyopneumoniae field isolates was determined in this study using a broth microdilution technique. Acquired resistance to spectinomycin, oxytetracycline, doxycycline, gentamicin, florfenicol and tiamulin was not observed. One isolate showed acquired resistance to lincomycin, tilmicosin and tylosin, but was susceptible to all other antibiotics tested. For 5 isolates, the MIC-values of flumequine were 16 μg/ml, while the MIC50-value was 2 μg/ml. The MIC-values of enrofloxacin for these 5 isolates were ≥ 0.5 μg/ml, the MIC50 being 0.06 μg/ml. This is the first report showing acquired resistance against macrolides, lincosamides and fluoroquinolones in M. hyopneumoniae field isolates.

UR - https://www.scopus.com/pages/publications/34548610280

UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-34548610280&origin=recordpage

U2 - 10.21825/vdt.87582

DO - 10.21825/vdt.87582

M3 - RGC 21 - Publication in refereed journal

SN - 0303-9021

VL - 76

SP - 300

EP - 305

JO - Vlaams Diergeneeskundig Tijdschrift

JF - Vlaams Diergeneeskundig Tijdschrift

IS - 4

ER -

Gevoeligheid van Belgische Mycoplasma hyopneumoniae-isolaten voor antimicrobiële middelen

Abstract

Bibliographical note

Access Output

Other Access Options

Permanent Link

Other Files and Links

Fingerprint

Cite this